Sam Carter
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
 | This article is a stub. |
Sam Carter or Samuel Carter is an advocate and a patient with myalgic encephalomyelitis.
Talks and interviews[edit | edit source]
Letters[edit | edit source]
- 2010, FINE trial for CFS. Both significant and small?[1]
- 2012, A valedictory dispatch from the Psychosocial School?[2]
- 2013, Letter to the Editor: ‘Recovery from chronic fatigue syndrome after treatments given in the PACE trial’: recovery or remission?[3]
- 2016, Exploring changes to PACE trial outcome measures using anonymised data from the FINE trial[4]
Online presence[edit | edit source]
- Website/Blog
- YouTube
See also[edit | edit source]
Learn more[edit | edit source]
References[edit | edit source]
- ↑ Carter, Sam (June 9, 2010). "FINE Trial for CFS: Both significant and small?". BMJ. 340: c2988. doi:10.1136/bmj.c2988. ISSN 0959-8138. PMID 20534659.
- ↑ Carter, Sam (June 9, 2012). "A valedictory dispatch from the Psychosocial School? | Rapid Responses to articles". The BMJ. Retrieved January 29, 2019.
- ↑ Carter, Samuel (July 19, 2013). "Letter to the Editor: 'Recovery from chronic fatigue syndrome after treatments given in the PACE trial': recovery or remission?". Psychological Medicine. 43 (8): 1787–1788. doi:10.1017/S0033291713001268. PMID 23866112.
- ↑ Carter, Sam (February 15, 2016). "Exploring changes to PACE trial outcome measures using anonymised data from the FINE trial". Psychological Medicine. Archived from the original on February 18, 2018.
